Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Combination With Platinum-Based Doublet Chemotherapy (PT-DC) in Advanced Non-Small Cell Lung Cancer (NSCLC)

被引：19

作者：

Antonia, S. J. ^{[1
]}

Brahmer, J. R. ^{[2
]}

Gettinger, S. ^{[3
]}

Chow, L. Q. ^{[4
]}

Juergens, R. ^{[5
]}

Shepherd, F. A. ^{[6
]}

Laurie, S. A. ^{[7
]}

Gerber, D. E. ^{[8
]}

Goldman, J. ^{[9
]}

Shen, Y. ^{[10
]}

Harbison, C. ^{[10
]}

Chen, A. C. ^{[10
]}

Borghaei, H. ^{[11
]}

Rizvi, N. A. ^{[12
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[2] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA

[3] Yale Canc Ctr, New Haven, CT USA

[4] Univ Washington, Seattle, WA 98195 USA

[5] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada

[6] Princess Margaret Canc Ctr, Toronto, ON, Canada

[7] Ottawa Hosp Canc Ctr, Hamilton, ON, Canada

[8] UT Southwestern Med Ctr, Dallas, TX USA

[9] Univ Calif Los Angeles, Los Angeles, CA USA

[10] Bristol Myers Squibb Co, Princeton, NJ USA

[11] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[12] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷

关键词：

D O I：

10.1016/j.ijrobp.2014.08.024

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S2 / S2

页数：1